🇺🇸 FDA
Patent

US 9587008

Method of producing recombinant vitamin K dependent proteins

granted A61KA61K38/36A61P

Quick answer

US patent 9587008 (Method of producing recombinant vitamin K dependent proteins) held by APTEVO BIOTHERAPEUTICS LLC expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
APTEVO BIOTHERAPEUTICS LLC
Grant date
Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/36, A61P, A61P7/04